The Effective Management of Fever in Pediatrics and Insights on Remote Management: Experts' Consensus Using a Delphi Approach.

Delphi process expert consensus fever pediatrics remote management

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 13 12 2021
accepted: 21 03 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 14 5 2022
Statut: epublish

Résumé

Even after the publication of the 2017 update of Italian guidelines on treatment of fever in pediatrics, some fundamental questions are still open and new ones emerged during the COVID-19 pandemic. To assess the level of consensus among Italian pediatricians on different topics related to treatment of fever in children by using the Delphi technique. A Delphi study was undertaken between June and September 2021, when two questionnaires were consecutively sent to a panel of experts to be answered anonymously. An invitation to participate was sent to 500 pediatricians distributed over the whole national territory and 80 (16%) of them accepted to participate on a voluntary basis. The questionnaires were structured into three specific topics: "therapeutic appropriateness and management of the febrile child," "management of the febrile child in the presence of other diseases," and "future perspectives in remote management." Each topic had six statements. A first-round questionnaire was sent to 80 accepting pediatricians from different Italian regions. Of the 72 respondents (23% working in hospitals and 72% outside), 33% were from northern, 12% central, and 55% southern Italy or islands. A second-round questionnaire was sent to the same 80 pediatricians and 69 of them responded, without significant differences for workplaces or geographical distribution as compared with the first questionnaire. Overall, 75 participants answered at least one of the two questionnaires. All the statements on the topics of "therapeutic appropriateness and management of the febrile child" and "future perspectives in remote management" reached the predefined cut off for consensus (75% or more). Only one statement on "management of the febrile child in the presence of other diseases" did not achieve the consensus even after the second round. Italian pediatricians agree on several aspects of treatment of febrile children and their expert opinions could support everyday decision process complementary to recommendations by regulatory agencies and guidelines.

Sections du résumé

Background UNASSIGNED
Even after the publication of the 2017 update of Italian guidelines on treatment of fever in pediatrics, some fundamental questions are still open and new ones emerged during the COVID-19 pandemic.
Objective UNASSIGNED
To assess the level of consensus among Italian pediatricians on different topics related to treatment of fever in children by using the Delphi technique.
Methods UNASSIGNED
A Delphi study was undertaken between June and September 2021, when two questionnaires were consecutively sent to a panel of experts to be answered anonymously. An invitation to participate was sent to 500 pediatricians distributed over the whole national territory and 80 (16%) of them accepted to participate on a voluntary basis. The questionnaires were structured into three specific topics: "therapeutic appropriateness and management of the febrile child," "management of the febrile child in the presence of other diseases," and "future perspectives in remote management." Each topic had six statements.
Results UNASSIGNED
A first-round questionnaire was sent to 80 accepting pediatricians from different Italian regions. Of the 72 respondents (23% working in hospitals and 72% outside), 33% were from northern, 12% central, and 55% southern Italy or islands. A second-round questionnaire was sent to the same 80 pediatricians and 69 of them responded, without significant differences for workplaces or geographical distribution as compared with the first questionnaire. Overall, 75 participants answered at least one of the two questionnaires. All the statements on the topics of "therapeutic appropriateness and management of the febrile child" and "future perspectives in remote management" reached the predefined cut off for consensus (75% or more). Only one statement on "management of the febrile child in the presence of other diseases" did not achieve the consensus even after the second round.
Conclusions UNASSIGNED
Italian pediatricians agree on several aspects of treatment of febrile children and their expert opinions could support everyday decision process complementary to recommendations by regulatory agencies and guidelines.

Identifiants

pubmed: 35558379
doi: 10.3389/fped.2022.834673
pmc: PMC9087841
doi:

Types de publication

Journal Article

Langues

eng

Pagination

834673

Informations de copyright

Copyright © 2022 Chiappini, Vitale, Badolato, Becherucci, Careddu, Di Mauro, Doria and Staiano.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Crit Care. 2019 Mar 7;23(1):69
pubmed: 30845977
Health Technol Assess. 1998;2(3):i-iv, 1-88
pubmed: 9561895
Pediatr Infect Dis J. 2019 Dec;38(12S Suppl):S10-S21
pubmed: 31876601
JAMA Netw Open. 2020 Oct 1;3(10):e2022398
pubmed: 33125495
J Pediatr. 2017 Jan;180:177-183.e1
pubmed: 27810155
Nurs Res. 2018 Sep/Oct;67(5):404-410
pubmed: 30052591
Ital J Pediatr. 2020 Sep 24;46(1):139
pubmed: 32972435
Cochrane Database Syst Rev. 2016 Dec 15;12:CD011534
pubmed: 27977844
Health Technol Assess. 2019 Feb;23(5):1-148
pubmed: 30793698
Inflammopharmacology. 2017 Feb;25(1):1-9
pubmed: 28063133
Arthritis Rheumatol. 2021 Apr;73(4):e13-e29
pubmed: 33277976
Int J Environ Res Public Health. 2021 Dec 19;18(24):
pubmed: 34948983
Children (Basel). 2021 Mar 28;8(4):
pubmed: 33800549
J Paediatr Child Health. 2017 Aug;53(8):800-807
pubmed: 28437025
BMC Pulm Med. 2020 Mar 23;20(1):72
pubmed: 32293369
J Adv Nurs. 2003 Feb;41(4):376-82
pubmed: 12581103
Ital J Pediatr. 2021 Jan 29;47(1):20
pubmed: 33514404
JAMA Pediatr. 2016 Aug 1;170(8):794-800
pubmed: 27322346
BMJ Open. 2017 Jul 31;7(7):e015404
pubmed: 28760789
Ital J Pediatr. 2020 Nov 16;46(1):170
pubmed: 33198780
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242

Auteurs

Elena Chiappini (E)

Pediatric Infectious Disease Unit, Anna Meyer Children's University Hospital, Florence, Italy.

Antonio Vitale (A)

Department of Pediatrics, Azienda Ospedaliera San Giuseppe Moscati, Avellino, Italy.

Raffaele Badolato (R)

Department of Clinical and Experimental Sciences, Pediatrics Clinic, University of Brescia and ASST-Spedali Civili, Brescia, Italy.

Paolo Becherucci (P)

Pediatric Primary Care, National Pediatric Health Care System, Lastra a Signa, Italy.

Domenico Careddu (D)

Pediatric Primary Care, National Pediatric Health Care System, Novara, Italy.

Antonio Di Mauro (A)

Pediatric Primary Care, National Pediatric Health Care System, Margherita di Savoia, Barletta-Andria-Trani, Italy.

Mattia Doria (M)

Pediatric Primary Care, National Pediatric Health Care System, Chioggia, Italy.

Annamaria Staiano (A)

Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Classifications MeSH